Endometriosis

The exact cause is not established. The grounding supports retrograde menstruation as a primary proposed mechanism, with additional contributions from congenital, environmental, epigenetic, autoimmune, and allergic factors. Microbiological dysbiosis has also been discussed as a possible contributor.

Ectopic endometrial tissue is thought to arise when endometrial progenitor or stem cells, or exfoliated endometrial cells, implant outside the uterus and expand locally. Once established, the tissue is maintained by chronic inflammation, immune surveillance abnormalities, and estrogen-related hormonal dysregulation. The literature also links innate immune changes, cytokine alterations, oxidative stress, and signaling pathways such as NF-κB to lesion persistence and progression.

The supplied grounding does not support specific patient-level risk factors in a way that can be stated cleanly. It does indicate associations with estrogen dependence, immune dysregulation, microbiota disturbances, and oxidative stress-related reproductive imbalance. It also notes that lifestyle factors such as cigarette smoking and alcohol use have been discussed in the broader oxidative stress literature, but not as established endometriosis-specific risk factors.

The grounding supports therapy at the modality level only, without specific regimens. Endometriosis is discussed in relation to hormonal treatment, particularly estrogen-related modulation, and broader management of inflammation and immune dysregulation. No specific standard treatment classes beyond this are sufficiently supported in the supplied material.